ArticleESMO open2024

What constitutes meaningful benefit of cancer drugs in the context of LMICs? A mixed-methods study of oncologists' perceptions on endpoints, benefit, price, and value of cancer drugs.

S S Datta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.